Table 2 Patient’s characteristics
Case Number | Age | Gender | FEV1 (%) | BMI | Pleural adhesions | PAL Score (grade) | Bronchodilatation treatment | ASA score | Diagnosis | Histological type | Pathological stage |
|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 62 | Male | 66.9 | 22.26 | Yes | 2.5 (C) | Yes | III | NSCLC | Large-cell neuroendocrine carcinoma | IIB |
2 | 70 | Male | 71.9 | 25.45 | No | 2.5 (C) | No | III | NSCLC | Adenocarcinoma | IA2 |
3 | 55 | Female | 79.9 | 17.90 | No | 3.5 (D) | Yes | II | NSCLC | Adenocarcinoma | IIA |
4 | 69 | Male | 78.6 | 23.68 | Yes | 3.5 (D) | No | III | NSCLC | Adenocarcinoma | IA2 |
5 | 64 | Male | 58.6 | 18.75 | Yes | 4.5 (D) | No | III | NSCLC | Adenocarcinoma | IA3 |
6 | 68 | Male | 63.4 | 25.00 | Yes | 3.5 (D) | Yes | III | Pulmonary nodule | Hamartoma | – |
7 | 64 | Male | 34.9 | 17.44 | No | 3.5 (D) | Yes | II | Pulmonary emphysema | Bullous emphysema | – |
8 | 73 | Male | 42.5 | 17.48 | No | 4.5 (D) | Yes | II | Pulmonary emphysema | Bullous emphysema | – |